Basic information Safety Supplier Related

Gemcitabine monophosphate

Basic information Safety Supplier Related

Gemcitabine monophosphate Basic information

Product Name:
Gemcitabine monophosphate
Synonyms:
  • Gemcitabine monophosphate disodium salt
  • Gemcitabine monophosphate disodium
  • GEMCITABINE MONOPHOSPHATE DISODIUM SALT MONOHYDRATE; GEMCITABINE MONOPHOSPHATE DISODIUM; GEMMP
  • GemMP
  • Gemcitabine monophosphate disodium monohydrate
  • 4-amino-1-((2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1h)-one, phosphate salt
CAS:
1638288-31-9
MF:
C9H13F2N3NaO7P
MW:
367.18
Mol File:
1638288-31-9.mol
More
Less

Gemcitabine monophosphate Chemical Properties

storage temp. 
Store at 0-8 °C
solubility 
DMSO:10.0(Max Conc. mg/mL);24.68(Max Conc. mM)
More
Less

Gemcitabine monophosphate Usage And Synthesis

Uses

Gemcitabine monophosphate (Gemcitabine 5′-phosphate) is one of the active intermediates of Gemcitabine (HY-17026). Gemcitabine monophosphate has a synergistic anti-cancer effect and can be delivered by formulating it into nanoparticles[1][2].

in vivo

Gemcitabine monophosphate (19.5 mg/kg, intravenous injection, every other day, four injections) combined with LCP loaded with VEGF siRNA and GMP shows anti-small cell lung cancer activity and induces apoptosis[1].

Animal Model:Subcutaneous and orthotopic xenograft mouse models of non-small cell lung cancer[1]
Dosage:19.5 mg/kg, every other day, four injections
Administration:Intravenous injection (i.v.)
Result:Induced tumor cell apoptosis to 30-40%, reduced tumor cell proliferation by 8 times, significantly reduced tumor microvessel density (MVD), and inhibited tumor mitosis.

References

[1] Zhang Y, et al. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. Mol Ther. 2013 Aug;21(8):1559-69. DOI:10.1038/mt.2013.120
[2] Miao L, et al. Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer. Adv Funct Mater. 2014 Nov 12;24(42):6601-6611. DOI:10.1002/adfm.201401076

Gemcitabine monophosphateSupplier

Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Email
3003855609@qq.com
Shanghai JiYi Biotechnology Co. Ltd.
Tel
13621943973
Email
sales@shjiyipharmatech.com
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Medi-tech Bioscientific Co., Ltd.
Tel
0519-83246372 13585352506
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Email
sales@invivochem.cn